The type III TGF-β receptor suppresses breast cancer progression
Mei Dong(Duke Medical Center), Gerard C. Blobe(Duke University Hospital)
Cited by 255
Related Papers
TGF-β-induced stromal CYR61 promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma through downregulation of the nucleoside transporters hENT1 and hCNT3
|Carcinogenesis|2016|106
ALK5 phosphorylation of the endoglin cytoplasmic domain regulates Smad1/5/8 signaling and endothelial cell migration
|Carcinogenesis|2009|70
The type III TGF-β receptor suppresses breast cancer progression through GIPC-mediated inhibition of TGF-β signaling
|Carcinogenesis|2009|60